(Q34155990)

31 July 2017

1 reference

title

Current issues with blood transfusions in sickle cell disease (English)

1 reference

31 July 2017

0 references

Vichinsky EP

1

1 reference

31 July 2017

language of work or name

1 reference

1 January 2001

1 reference

31 July 2017

published in

Seminars in Hematology

1 reference

31 July 2017

volume

38

1 reference

31 July 2017

issue

1 Suppl 1

1 reference

31 July 2017

page(s)

14-22

1 reference

Infection due to Yersinia enterocolitica in a series of patients with beta-thalassemia: incidence and predisposing factors

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

HLA-B35 is associated with red cell alloimmunization in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Delayed hemolytic transfusion reaction due to anti-Js(a) in an alloimmunized patient with a sickle cell syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Viral burden and disease progression in HIV-1-infected patients with sickle cell anemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Broadening the base of a rare donor program by targeting minority populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

The photodecontamination of cellular blood components: mechanisms and use of photosensitization in transfusion medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Passenger leukocytes, cytokines, and transfusion reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Clinical significance of white cell antibodies in febrile nonhemolytic transfusion reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Subarachnoid hemorrhage in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Aplastic crisis in sickle cell disorders: bone marrow necrosis and human parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Cytokine roles in hemolytic and nonhemolytic transfusion reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Red cell alloimmunization in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence. French Study Group on Sickle Cell Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Delayed hemolytic transfusion reaction presenting as sickle-cell crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

The risk of transfusion-transmitted infection

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Effect of transfusion in acute chest syndrome of sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

The haemochromatosis gene: a co-factor for chronic liver diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Severe pneumococcal sepsis and meningitis in human immunodeficiency virus-infected adults with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Possible autoantibody binding to sickle erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Management of hepatitis C: current and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Effects of total hemoglobin and hemoglobin S concentration on cerebral blood flow during transfusion therapy to prevent stroke in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Studies of antibodies in the sera of patients who have made red cell autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Multifocal osteosarcoma: an unusual presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Systemic lupus erythematosus and sickle hemoglobinopathies: a report of two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Antiphospholipid antibodies in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Leukocyte Reduction in Blood Component Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Delayed hemolytic transfusion reaction due to anti-Goa, an antibody against the low-prevalence Gonzales antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and review

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Human parvoviruses: implications for transfusion medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Yersinia enterocolitica and white cell filtration

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Association of HLA and autoantibody in transfused sickle cell disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Post-transfusion alloimmunization in patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

The sickle cell hemolytic transfusion reaction syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Neurologic events after partial exchange transfusion for priapism in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

B19 parvovirus infection and transient aplastic crisis in a child with sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Alloantibody responses in multiply transfused sickle cell patients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Comparison of the polyethylene glycol antiglobulin test and the use of enzymes in antibody detection and identification

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Screening with monoclonal anti-Fy3 to provide blood for phenotype-matched transfusions for patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Association of sickle cell disease, priapism, exchange transfusion and neurological events: ASPEN syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

A simple, practical model for reducing alloimmunization in patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Effects of a long-term transfusion regimen on sickle cell-related illnesses

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Case reports: delayed hemolytic transfusion reaction in sickle cell disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Antigen-matched donor blood in the transfusion management of patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Acute lung injury due to parvovirus pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

A syndrome of hypertension, convulsion, and cerebral haemorrhage in thalassaemic patients after multiple blood-transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Alphabet of hepatitis viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Human parvovirus B19 infection among hospital staff members after contact with infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

Febrile nonhemolytic transfusion reactions to platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990056-3

7 January 2021

10.1016/S0037-1963(01)90056-3

Identifiers

DOI

1 reference

31 July 2017

1 reference